NSE: BANKA
BANKA BIOLOO LIMITED
Provides water, sanitation and hygiene (WaSH) solutions, with work split between a Railways business and a commercial real estate WaSH business. The WaSH side builds and services sanitation and hygiene infrastructure for corporate real estate clients, including projects in Bangalore and Mumbai for Brigade, Reliance and RMZ. The Railways side provides sanitation systems to Indian Railways. FY26 consolidated revenue was ₹57.09 crore, with the company swinging to a net profit of ₹0.39 crore from a loss the prior year, on consolidated EBITDA margin of 10.85%. Employee cost is the largest input at 48.7% of revenue, and was reduced 19.1% YoY to drive the turnaround. Trade receivables of ₹6.87 crore (25% of total) are owed by government bodies, with ₹1.25 crore overdue over 2 years, and a wholly-owned subsidiary Enzotech Solutions is under NCLT insolvency proceedings. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. WaSH (Water, Sanitation and Hygiene), Railways. Small-cap WaSH services company serving government and commercial real estate clients
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 39 | 42 | 50 | 54 | 57 |
| EBITDA (ex other income) | 6 | 6 | 4 | (3) | 5 |
| margin % | 14.2 | 14.0 | 7.3 | (5.9) | 8.6 |
| Owners' profit | 0 | 0 | (0) | (9) | 0 |
| EPS, as reported (₹) | 3.02 | 2.39 | (0.60) | (8.21) | 0.32 |
| ROE % · ROCE % | — · — | 6.3 · 11.1 | (1.7) · 3.7 | (28.2) · (12.2) | 0.9 · 5.8 |
| Debt / equity (x) | — | 0.37 | 0.62 | 1.08 | 0.92 |
| Cash from operations | (0) | 10 | 3 | 1 | 1 |
| Capex | (3) | (6) | (10) | (4) | (6) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 14 | 15 | 11 | 13 | 15 | 18 | 11 |
| Profit before tax | (6) | (1) | (2) | (0) | (2) | (0) | 2 | (0) |
| Net profit | (6) | (1) | (2) | 0 | (1) | (0) | 2 | (0) |
| EPS (₹) | (5.65) | (1.34) | (1.50) | 0.00 | (1.00) | (0.14) | 1.45 | (0.01) |
Exhibit 3: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 25 Sept 2026 · Trading window closed from Oct 1 ahead of Q2 FY27 results | compliance | minimal | — | — |
| 21 Sept 2026 · AGM voting results: all 3 resolutions passed with 100% support | board shareholder meetings | medium | — | — |
| 18 Sept 2026 · Banka BioLoo AGM FY26: PAT turns positive, FY27 cash and PBT focus | investor communications | medium | — | — |
| 17 Sept 2026 · Banka BioLoo holds 14th AGM on 17 Sep 2026; 3 resolutions voted on | board shareholder meetings | low | — | — |
| 26 Aug 2026 · Banka BioLoo 14th AGM Notice Published in Newspapers | compliance | minimal | — | — |
| 26 Aug 2026 · 14th AGM on Sep 17, 2026 via video conferencing; 3 items on agenda | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Book closure and e-voting details announced for 14th AGM on 17 Sept 2026 | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Banka BioLoo 14th AGM on 17 Sep; book closure from 11 to 17 Sep | board shareholder meetings | low | — | — |
| 25 Aug 2026 · AGM notice for September 17, 2026 with material related party transaction approval | board shareholder meetings | low | — | — |
| 21 Aug 2026 · Banka BioLoo files newspaper notice for 14th AGM on 17 Sep 2026 | compliance | minimal | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.